Chronic pancreatitis is the progressive disorder associated with the destruction of the pancreas. Initially, chronic pancreatitis may be confused with acute pancreatitis because the symptoms are similar. The most common symptoms are upper abdominal pain and diarrhea. As the disease becomes more chronic, patients can develop malnutrition and weight loss. If the pancreas becomes destroyed in the latter stages of the disease, patients may develop diabetes mellitus.
Chronic pancreatitis can lead to permanent scarring and damage. Calcium stones and cysts may develop in your pancreas, which can block the duct, or tube, that carries digestive enzymes and juices to your stomach. The blockage may lower the levels of pancreatic enzymes and hormones, which will make it harder for your body to digest food and regulate your blood sugar.
DelveInsight's "Chronic Pancreatitis Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Chronic Pancreatitis, historical and forecasted epidemiology as well as the Chronic Pancreatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Chronic Pancreatitis Market Key Facts
According to the National Pancreas Foundation, the prevalence of chronic pancreatitis is 50/100,000 people. Chronic pancreatitis often develops in patients between the ages of 30 and 40.
Prevalence estimates for CP are limited to only a few populations. The overall prevalence of CP shows high variability. In recent studies the prevalence ranges around 40-50 per 100,000 population.
Non-alcoholic etiologies are identified more frequently among women, and can account for up to 70% of cases
Hospitalization in patients with CP could be due to AP flares, pain, maldigestion, and local complications. More than 90% of patients are hospitalized on at least one occasion in their lifetime for pain related to CP.
Chronic Pancreatitis is found to be more common in men than women.
The Chronic Pancreatitis market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Chronic Pancreatitis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Chronic Pancreatitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
The Chronic Pancreatitis epidemiology section covers insights about historical and current Chronic Pancreatitis patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The Chronic Pancreatitis Pipeline Analysis section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Pancreatitis market or expected to get launched in the market during the study period. The analysis covers Chronic Pancreatitis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Pipeline Insight section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
And many others
For more detailed information on Chronic Pancreatitis Market, visit: https://www.delveinsight.com/report-store/chronic-pancreatitis-market